Hepatic transporter drug-drug interactions: an evaluation of approaches and methodologies

• Published in: Expert opinion on drug metabolism & toxicology Vol. 13; no. 12; p. 1237
• Main Authors: Williamson, Beth, Riley, Robert J
• Format: Journal Article
• Language: English
• Published: England 02.12.2017
• Subjects: pharmacokinetics; drug-drug interactions; hepatic drug transporters; ADME
• ISSN: 1744-7607
• DOI: 10.1080/17425255.2017.1404028

Drug-drug interactions (DDIs) continue to account for 5% of hospital admissions and therefore remain a major regulatory concern. Effective, quantitative prediction of DDIs will reduce unexpected clinical findings and encourage projects to frontload DDI investigations rather than concentrating on risk management ('manage the baggage') later in drug development. A key challenge in DDI prediction is the discrepancies between reported models. Areas covered: The current synopsis focuses on four recent influential publications on hepatic drug transporter DDIs using static models that tackle interactions with individual transporters and in combination with other drug transporters and metabolising enzymes. These models vary in their assumptions (including input parameters), transparency, reproducibility and complexity. In this review, these facets are compared and contrasted with recommendations made as to their application. Expert opinion: Over the past decade, static models have evolved from simple [I]/k models to incorporate victim and perpetrator disposition mechanisms including the absorption rate constant, the fraction of the drug metabolised/eliminated and/or clearance concepts. Nonetheless, models that comprise additional parameters and complexity do not necessarily out-perform simpler models with fewer inputs. Further, consideration of the property space to exploit some drug target classes has also highlighted the fine balance required between frontloading and back-loading studies to design out or 'manage the baggage'.